Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)

NCT01371656 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT01371656
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01371656 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Lead sponsor
Children's Oncology Group
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2011
Completion date
June 30, 2017
Enrollment
624 (actual)
Sites
84

Conditions

As the registry lists them; a condition with its own page is linked.

acute leukemias of ambiguous lineage, bacterial infection, diarrhea, fungal infection, musculoskeletal complications, neutropenia, recurrent childhood acute lymphoblastic leukemia, recurrent childhood acute myeloid leukemia, secondary acute myeloid leukemia, untreated childhood acute myeloid leukemia and other myeloid malignancies